MiR-3613-5p targets AQP4 to promote the progression of chronic atrophic gastritis to gastric cancer. [PDF]
Bi J, Wang Y, Wang Y.
europepmc +1 more source
Evaluation of Pepsinogen I, II, Gastrin 17 and Helicobacter pylori IgG in Atrophic Gastritis: A Head-To-Head Comparison of Lateral Flow and Enzyme-Linked Immunosorbent Assays. [PDF]
Xiang L +7 more
europepmc +1 more source
Autoimmune chronic atrophic gastritis: association between chronic proton pump inhibitors use and more severe atrophy and gastric intestinal metaplasia. [PDF]
Calabrese F +10 more
europepmc +1 more source
Vitamin C Mediates IGFBP7 to Alleviate Chronic Atrophic Gastritis via the HIF-1α/VEGF Pathway. [PDF]
Cheng X +9 more
europepmc +1 more source
Current study of pathogenetic mechanisms and therapeutics of chronic atrophic gastritis: a comprehensive review. [PDF]
Kuang W +8 more
europepmc +1 more source
Unveiling the therapeutic effects of traditional Chinese patent medicines: A network meta-analysis on chronic atrophic gastritis. [PDF]
Ren B +10 more
europepmc +1 more source
Characterization of Immune-Related circRNAs and mRNAs in Human Chronic Atrophic Gastritis. [PDF]
Chao Y +5 more
europepmc +1 more source
Related searches:
Current Perspectives in Atrophic Gastritis
Current Gastroenterology Reports, 2020Atrophic gastritis is a complex syndrome with gastric atrophy as a common trait. Helicobacter pylori infection and autoimmunity are the two main contexts in which it develops. It is slightly symptomatic, affects various aspects of general health, and remains a predisposing factor for gastric cancer.
Lahner E. +3 more
openaire +4 more sources

